{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:15:54Z","timestamp":1791227754537,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Transl Oncol"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1007\/s12094-009-0438-3","type":"journal-article","created":{"date-parts":[[2009,12,3]],"date-time":"2009-12-03T13:13:53Z","timestamp":1259846033000},"page":"753-759","source":"Crossref","is-referenced-by-count":56,"title":["The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer"],"prefix":"10.1007","volume":"11","author":[{"given":"Francisco C.","family":"Mu\u00f1oz-Casares","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Rufi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda J.","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos J.","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngela","family":"Casado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1lvaro","family":"Arjona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda C.","family":"Mu\u00f1oz-Villanueva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Muntan\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,12,4]]},"reference":[{"key":"438_CR1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00000658-199501000-00004","volume":"221","author":"P.H. Sugarbaker","year":"1995","unstructured":"Sugarbaker PH (1995) Peritonectomy procedures. Ann Surg 221:29\u201342","journal-title":"Ann Surg"},{"key":"438_CR2","first-page":"207","volume":"41","author":"D. Elias","year":"1994","unstructured":"Elias D, Detroz B, Debaene B et al (1994) Treatment peritoneal carcinomatosis by intraperitoneal chemo-hyperthermia: reliable and unreliable concepts. Hepato-Gastroenterol 41:207\u2013213","journal-title":"Hepato-Gastroenterol"},{"key":"438_CR3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S0003-3944(00)00253-4","volume":"125","author":"Y. Rey","year":"2000","unstructured":"Rey Y, Porcheron J, Talabard JN et al (2000) Carcinoses p\u00e9riton\u00e9ales trait\u00e9es par chirurgie de r\u00e9duction tumorale et chimiohyperthermie intrap\u00e9riton\u00e9ale. Ann Chir 125:631\u2013642","journal-title":"Ann Chir"},{"key":"438_CR4","first-page":"1435","volume":"15","author":"J. Jahne","year":"1998","unstructured":"Jahne J, Piso P (1998) Peritonectomy and intraperitoneal chemotherapy: new methods in multimodality therapy of peritoneal carcinosis. Langenbecks Arch Chir Suppl Kongressbd 15:1435\u20131437","journal-title":"Langenbecks Arch Chir Suppl Kongressbd"},{"key":"438_CR5","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","volume":"58","author":"A. Jemal","year":"2008","unstructured":"Jemal A, Siegel RT, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58:71\u201396","journal-title":"CA Cancer J Clin"},{"key":"438_CR6","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1111\/j.1525-1438.2003.13368.x","volume":"13","author":"A. Poveda","year":"2003","unstructured":"Poveda A (2003) Ovarian cancer treatment: what is new. Int J Gynecol Cancer 13:241\u2013250","journal-title":"Int J Gynecol Cancer"},{"key":"438_CR7","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/(SICI)1098-2388(199804\/05)14:3<254::AID-SSU10>3.0.CO;2-U","volume":"14","author":"P.H. Sugarbaker","year":"1998","unstructured":"Sugarbaker PH (1998) Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Semin Surg Oncol 14:254\u2013261","journal-title":"Semin Surg Oncol"},{"key":"438_CR8","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1080\/00015458.2004.11679550","volume":"104","author":"I. Vergote","year":"2004","unstructured":"Vergote I (2004) Role of surgery in ovarian cancer: an update. Acta Chir Belg 104:246\u2013256","journal-title":"Acta Chir Belg"},{"key":"438_CR9","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","volume":"20","author":"R.E. Bristow","year":"2002","unstructured":"Bristow RE, Tomacruz RS, Armstrong DK et al (2002) Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. J Clin Oncol 20:1248\u20131259","journal-title":"J Clin Oncol"},{"key":"438_CR10","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","volume":"170","author":"W.J. Hoskins","year":"1994","unstructured":"Hoskins WJ, McGuire WP, Brady MF et al (1994) The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma. Am J Obstet Gynecol 170:974\u2013980","journal-title":"Am J Obstet Gynecol"},{"key":"438_CR11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","volume":"47","author":"W.J. Hoskins","year":"1992","unstructured":"Hoskins WJ, Bundy BN, Thigpen JT, Omura GA (1992) The influence of cytoreductive surgery on recurrence-free interval and survival in smallvolume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study. Gynecol Oncol 47:159\u2013166","journal-title":"Gynecol Oncol"},{"key":"438_CR12","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/978-1-4613-1245-1_8","volume":"81","author":"P.H. Sugarbaker","year":"1996","unstructured":"Sugarbaker PH (1996) Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. Cancer Treat Res 81:75\u201387","journal-title":"Cancer Treat Res"},{"key":"438_CR13","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1093\/annonc\/mdm137","volume":"18","author":"L. Bijelic","year":"2007","unstructured":"Bijelic L, Jonson A, Sugarbaker PH (2007) Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer. Ann Oncol 18:1943\u20131950","journal-title":"Ann Oncol"},{"key":"438_CR14","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ygyno.2004.05.044","volume":"94","author":"K.S. Ryu","year":"2004","unstructured":"Ryu KS, Kim JH, Ko HS et al (2004) Effects of intraperitoneal hyperthermic chemotherapybin ovarian cancer. Gynecol Oncol 94:325\u2013332","journal-title":"Gynecol Oncol"},{"key":"438_CR15","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.20597","volume":"94","author":"S. Rufi\u00e1n","year":"2006","unstructured":"Rufi\u00e1n S, Mu\u00f1oz-Casares FC, Brice\u00f1o J et al (2006) Radical surgery-peritonectomy and intraoperative intraperitoneal chemotherapy for the treatment of peritoneal carcinomatosis in recurrent o primary ovarian cancer. J Surg Oncol 94:316\u2013324","journal-title":"J Surg Oncol"},{"key":"438_CR16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1053\/ejso.2002.1380","volume":"29","author":"A.A. Tentes","year":"2003","unstructured":"Tentes AA, Tripsiannis G, Markakidis SK et al (2003) Peritoneal cancer index: a prognostic indicator of survival in advanced ovarian cancer. Eur J Surg Oncol 29:69\u201373","journal-title":"Eur J Surg Oncol"},{"key":"438_CR17","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.sla.0000133083.54934.ae","volume":"240","author":"D. Dindo","year":"2004","unstructured":"Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications. A new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240:205\u2013213","journal-title":"Ann Surg"},{"key":"438_CR18","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1007\/s12094-007-0118-0","volume":"9","author":"F.C. Mu\u00f1oz-Casares","year":"2007","unstructured":"Mu\u00f1oz-Casares FC, Rufi\u00e1n S, Rubio MJ et al (2007) Treatment of peritoneal carcinomatosis from ovarian cancer. Present, future directions and proposals. Clin Transl Oncol 9:652\u2013662","journal-title":"Clin Transl Oncol"},{"key":"438_CR19","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1517\/14656566.3.6.755","volume":"3","author":"T.M. Mekhail","year":"2002","unstructured":"Mekhail TM, Markman M (2002) Paclitaxel in cancer therapy. Expert Opin Pharmacother 3:755\u2013766","journal-title":"Expert Opin Pharmacother"},{"key":"438_CR20","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1200\/JCO.1992.10.9.1485","volume":"10","author":"M. Markman","year":"1992","unstructured":"Markman M, Rowinsky E, Hakes T et al (1992) Phase I trial of intraperitoneal taxol: a Gynecologic Oncology Group study. J Clin Oncol 10:1485\u20131491","journal-title":"J Clin Oncol"},{"key":"438_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-2388(199910\/11)17:3<181::AID-SSU7>3.0.CO;2-7","volume":"17","author":"V.E. Herrin","year":"1999","unstructured":"Herrin VE, Thigpen JT (1999) Chemotherapy for ovarian cancer: current concepts. Semin Surg Oncol 17:181\u2013188","journal-title":"Semin Surg Oncol"},{"key":"438_CR22","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/j.ejso.2006.03.008","volume":"32","author":"E. Bree de","year":"2006","unstructured":"de Bree E, Rosing H, Michalakis J et al (2006) Intraperitoneal chemotherapy with taxanes for ovarian cancer with peritoneal dissemination. Eur J Surg Oncol 32:666\u2013670","journal-title":"Eur J Surg Oncol"},{"key":"438_CR23","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1245\/s10434-007-9792-y","volume":"15","author":"E. Bree de","year":"2008","unstructured":"de Bree E, Rosing H, Filis D et al (2008) Cytoreductive surgery and intraoperative hiperthermic intraperitoneal chemotherapy with paclitaxel: A clinical and pharmacokinetic study. Ann Surg Oncol 15:1183\u20131192","journal-title":"Ann Surg Oncol"},{"key":"438_CR24","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.ygyno.2007.03.019","volume":"106","author":"J.H. Bae","year":"2007","unstructured":"Bae JH, Lee JM, Ryu KS et al (2007) Treatment of ovarian cancer with paclitaxel or carboplatinbased intraperitoneal hyperthermic chemotherapy during secondary surgery. Gynecol Oncol 106: 193\u2013209","journal-title":"Gynecol Oncol"},{"key":"438_CR25","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejso.2006.03.011","volume":"32","author":"F. Raspagliesi","year":"2006","unstructured":"Raspagliesi F, Kusamura S, Campos Torres JC et al (2006) Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced\/recurrent ovarian cancer patients: the experience of National Cancer Institute of Milan. Eur J Surg Oncol 32:671\u2013675","journal-title":"Eur J Surg Oncol"},{"key":"438_CR26","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1053\/ejso.2000.0978","volume":"26","author":"N. Vange van der","year":"2000","unstructured":"van der Vange N, van Goethem AR, Zoetmulder FA et al (2000) Extensive cytoreductive surgery combined with intra-operative intraperitoneal perfusion with cisplatin under hyperthermic conditions (OVHIPEC) in patients with recurrent ovarian cancer: a feasibility pilot. Eur J Surg Oncol 26:663\u2013668","journal-title":"Eur J Surg Oncol"},{"key":"438_CR27","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s10434-999-0790-0","volume":"6","author":"A.D. Stephens","year":"1999","unstructured":"Stephens AD, Alderman R, Chang D et al (1999) Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the coliseum technique. Ann Surg Oncol 6:790\u2013796","journal-title":"Ann Surg Oncol"},{"key":"438_CR28","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1272\/jnms.67.5","volume":"67","author":"P.H. Sugarbaker","year":"2000","unstructured":"Sugarbaker PH (2000) It\u2019s what the surgeon doesn\u2019t see that kills the patient. J Nippon Med Sch 67:5\u20138","journal-title":"J Nippon Med Sch"},{"key":"438_CR29","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1586\/14737140.4.3.477","volume":"4","author":"C.P. Carmignani","year":"2004","unstructured":"Carmignani CP, Sugarbaker PH (2004) Comprehensive approach to advanced primary and recurrent ovarian cancer. a personal experience. Exp Rev Anticancer Ther 4:477\u2013487","journal-title":"Exp Rev Anticancer Ther"},{"key":"438_CR30","doi-asserted-by":"crossref","first-page":"1950","DOI":"10.1056\/NEJM199612263352603","volume":"335","author":"D.S. Alberts","year":"1996","unstructured":"Alberts DS, Liu PY, Hannigan EV et al (1996) Intraperitoneal cisplatin plus intravenous cyclophosphamide versus intravenous cisplatin plus intravenous cyclophosphamide for stage III ovarian cancer. N Engl J Med 335:1950\u20131955","journal-title":"N Engl J Med"},{"key":"438_CR31","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1200\/JCO.2001.19.4.1001","volume":"19","author":"M. Markman","year":"2001","unstructured":"Markman M, Bundy BN, Alberts DS et al (2001) Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group. J Clin Oncol 19:1001\u20131007","journal-title":"J Clin Oncol"},{"key":"438_CR32","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1056\/NEJMoa052985","volume":"354","author":"D.K. Armstrong","year":"2006","unstructured":"Armstrong DK, Bundy B, Wenzel L et al (2006) Intraperitoneal cisplatin and paclitaxel in ovarian cancer. N Engl J Med 354:34\u201343","journal-title":"N Engl J Med"}],"container-title":["Clinical and Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-009-0438-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12094-009-0438-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12094-009-0438-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T03:50:47Z","timestamp":1559447447000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12094-009-0438-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["438"],"URL":"https:\/\/doi.org\/10.1007\/s12094-009-0438-3","relation":{},"ISSN":["1699-048X","1699-3055"],"issn-type":[{"value":"1699-048X","type":"print"},{"value":"1699-3055","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}